211 related articles for article (PubMed ID: 25100119)
1. Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trials.
Xu J; Ma R; Chen LF; Zhao LJ; Chen K; Zhang RB
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):354-60. PubMed ID: 25100119
[TBL] [Abstract][Full Text] [Related]
2. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.
Cao Q; Yu CB; Yang SG; Cao HC; Chen P; Deng M; Li LJ
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):9-16. PubMed ID: 29428113
[TBL] [Abstract][Full Text] [Related]
3. Probiotics for patients with hepatic encephalopathy.
McGee RG; Bakens A; Wiley K; Riordan SM; Webster AC
Cochrane Database Syst Rev; 2011 Nov; (11):CD008716. PubMed ID: 22071855
[TBL] [Abstract][Full Text] [Related]
4. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
[TBL] [Abstract][Full Text] [Related]
5. Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials.
Saab S; Suraweera D; Au J; Saab EG; Alper TS; Tong MJ
Liver Int; 2016 Jul; 36(7):986-93. PubMed ID: 26561214
[TBL] [Abstract][Full Text] [Related]
6. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Agrawal A; Sharma BC; Sharma P; Sarin SK
Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
[TBL] [Abstract][Full Text] [Related]
7. Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.
Gupta N; Kumar A; Sharma P; Garg V; Sharma BC; Sarin SK
Liver Int; 2013 Sep; 33(8):1148-57. PubMed ID: 23601333
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy: A Systematic Review.
Viramontes Hörner D; Avery A; Stow R
J Clin Gastroenterol; 2017 Apr; 51(4):312-323. PubMed ID: 28059938
[TBL] [Abstract][Full Text] [Related]
9. Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis.
Qamar AA
J Clin Gastroenterol; 2015; 49 Suppl 1():S28-32. PubMed ID: 26447961
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta-analysis involving 826 patients based on 10 randomized controlled trials.
Cai XJ; Wang L; Hu CM
J Cell Biochem; 2018 Nov; 119(10):8336-8345. PubMed ID: 29932239
[TBL] [Abstract][Full Text] [Related]
11. Probiotics in management of hepatic encephalopathy.
Sharma BC; Singh J
Metab Brain Dis; 2016 Dec; 31(6):1295-1301. PubMed ID: 27121846
[TBL] [Abstract][Full Text] [Related]
12. Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy.
Bongaerts G; Severijnen R; Timmerman H
Med Hypotheses; 2005; 64(1):64-8. PubMed ID: 15533613
[TBL] [Abstract][Full Text] [Related]
13. [Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis].
Lata J; Juránková J; Príbramská V; Fric P; Senkyrík M; Díte P; Kroupa R
Vnitr Lek; 2006 Mar; 52(3):215-9. PubMed ID: 16722152
[TBL] [Abstract][Full Text] [Related]
14. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
Ma YY; Li L; Yu CH; Shen Z; Chen LH; Li YM
World J Gastroenterol; 2013 Oct; 19(40):6911-8. PubMed ID: 24187469
[TBL] [Abstract][Full Text] [Related]
15. Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis.
Xia X; Chen J; Xia J; Wang B; Liu H; Yang L; Wang Y; Ling Z
J Int Med Res; 2018 Sep; 46(9):3596-3604. PubMed ID: 29806520
[TBL] [Abstract][Full Text] [Related]
16. Alterations of gut microbiome and effects of probiotic therapy in patients with liver cirrhosis: A systematic review and meta-analysis.
Huang L; Yu Q; Peng H; Zhen Z
Medicine (Baltimore); 2022 Dec; 101(51):e32335. PubMed ID: 36595801
[TBL] [Abstract][Full Text] [Related]
17. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.
Liu Q; Duan ZP; Ha DK; Bengmark S; Kurtovic J; Riordan SM
Hepatology; 2004 May; 39(5):1441-9. PubMed ID: 15122774
[TBL] [Abstract][Full Text] [Related]
18. Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo.
Varakanahalli S; Sharma BC; Srivastava S; Sachdeva S; Dahale AS
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):951-958. PubMed ID: 29727385
[TBL] [Abstract][Full Text] [Related]
19. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
[TBL] [Abstract][Full Text] [Related]
20. Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.
Dhiman RK; Rana B; Agrawal S; Garg A; Chopra M; Thumburu KK; Khattri A; Malhotra S; Duseja A; Chawla YK
Gastroenterology; 2014 Dec; 147(6):1327-37.e3. PubMed ID: 25450083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
